导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -0.75% | 574/1050 |
| 近一周 | -1.78% | 314/1104 |
| 近一月 | -3.64% | 430/1102 |
| 近一季 | -7.63% | 558/1092 |
| 近半年 | -1.30% | 457/1070 |
| 近一年 | 2.15% | 533/1018 |
| 近两年 | 41.47% | 568/926 |
| 近三年 | 5.22% | 621/834 |
| 成立以来 | 45.96% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-3.20% 727/1070 |
10.49% 535/1101 |
- - |
- - |
| 2025 | 20.04% 669/1065 |
1.41% 691/1014 |
3.40% 402/1038 |
12.10% 805/1050 |
2.14% 291/1065 |
| 2024 | -15.23% 863/1011 |
-12.35% 831/960 |
-11.16% 892/983 |
11.79% 472/991 |
-2.62% 501/1011 |
| 2023 | -0.68% 110/952 |
5.39% 301/880 |
-2.51% 337/895 |
-6.54% 394/915 |
3.44% 36/952 |
| 2022 | -15.53% 189/867 |
-14.76% 249/773 |
6.53% 433/806 |
-9.45% 210/845 |
2.73% 287/867 |
| 2021 | -8.61% 471/740 |
-6.19% 389/580 |
10.27% 348/659 |
-6.11% 390/704 |
-5.90% 612/740 |
| 2020 | 35.46% 327/554 |
-0.47% 171/419 |
14.61% 360/466 |
12.67% 189/517 |
5.40% 429/554 |
| 2019 | 45.13% 184/410 |
26.49% 593/1149 |
-1.18% 455/1231 |
6.21% 176/390 |
9.31% 182/410 |
| 2018 | -19.45% 66/349 |
- - |
- - |
- - |
-12.66% 680/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.69% |
| 招商医药健康产业股票 | 2.5730 | 48.73% |
| 嘉实医疗保健股票 | 2.5780 | 39.05% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 广发医药精选股票C | 1.2923 | 38.32% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 交银医药创新股票C | 3.0594 | 35.86% |
| 交银医药创新股票A | 2.8810 | 32.85% |
| 德邦量化优选股票(LOF)A VS. 东吴新产业精选股票A(580008) |